Inflammation | Page 2 | European Cystic Fibrosis Society (ECFS)

Results of a clinical evaluation of the safety and efficacy of the therapeutic drug candidate Roscovitine in people with cystic fibrosis.

What do we already know and what do we need to study next when looking at markers of inflammation in sputum in CF trials?

Study that tested the effects of a new drug called acebilustat in adultswith cystic fibrosis

Alpha-1 Antitrypsin for Cystic Fibrosis Complicated by Severe Cytokinemic COVID-19

Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis

Neutrophil Dysfunction in Cystic Fibrosis

Changes in airway inflammation with pseudomonas eradication in early cystic fibrosis

Evaluation of airway and circulating inflammatory biomarkers for cystic fibrosis drug development

Global assessment of the integrated stress response in CF patient-derived airway and intestinal tissues

Circulating CRP and calprotectin to diagnose CF pulmonary exacerbations